[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334457-105":59,"doc-detail-334457-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-zinc-metabolism-related-gene-signature-for-predicting-prognosis-and-characteristics-of-breast-cancer","A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer","","Breast cancer remains a leading cause of cancer mortality, and the role of zinc in its progression lacks mechanistic clarity. This study built a zinc metabolism-related gene (ZMRG) signature using multi-database RNA profiles to forecast patient prognosis and to examine links between drug response and immune enrichment. Five ZMRGs were identified and two risk groups showed distinct outcomes. Tumour microenvironment analyses connected ZMRG expression with immune responses and drug sensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-zinc-metabolism-related-gene-signature-for-predicting-prognosis-and-characteristics-of-breast-cancer/334457/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-zinc-metabolism-related-gene-signature-for-predicting-prognosis-and-characteristics-of-breast-cancer/334457.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study designed to achieve regarding zinc and breast cancer?","Question",{"text":112,"@type":113},"To develop a zinc metabolism-related gene (ZMRG) signature that predicts prognosis and clarifies how zinc-related genes relate to drug therapy response and immune enrichment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many ZMRGs were identified, and what does the signature do?",{"text":117,"@type":113},"Five ZMRGs (ATP7B, BGLAP, P2RX4, SLC39A11, and TH) were identified, and the signature generated risk profiles that split patients into high- and low-risk groups.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about high-risk patients and tumour microenvironment?",{"text":121,"@type":113},"High-risk groups showed worse prognosis and displayed substantial immune cell infiltration and enrichment of immune pathways, with higher sensitivity to commonly used breast cancer drugs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334457,1791198633,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","TYPE Original Research PUBLISHED 08 January 2024  \nDOI 10.3389/fimmu.2023.1276280  \nOPEN ACCESS  \nEDITED BY  \nSimona Kranjc Brezar, Department of Experimental Oncology, Slovenia  \nREVIEWED BY  \nRemya Nair,  \nEmory University, United States Subhash Kumar Tripathi,  \nSeattle Children’s Research Institute, United States  \n*CORRESPONDENCE Dong Song  \n [songdong@jlu.edu.cn](songdong@jlu.edu.cn)  \nRECEIVED 11 August 2023  \nACCEPTED 18 December 2023  \nPUBLISHED 08 January 2024  \nCITATION  \nHong J, Li M, Chen Y, Du Y and Song D (2024) A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer.  \nFront. Immunol. 14:1276280 .  \ndoi: 10.3389/fimmu.2023.1276280  \nCOPYRIGHT  \n© 2024 Hong, Li, Chen, Du and Song. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nA zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer  \nJinghui Hong, Mengxin Li, Yichang Chen, Ye Du and Dong Song*  \nDepartment of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China  \nBackground: Breast cancer is one of the most serious and prevalent malignancies. Zinc is commonly known to play a crucial role in the development and progression of breast cancer; however, the detailed mechanisms underlying this role are not well understood. This study aimed to develop a zinc metabolism-related gene (ZMRG) signature based on a multidatabase study to predict patient prognosis and investigate the relationship between drug therapy response and immune enrichment.  \nMethods: Data for breast cancer samples from The Cancer Genome Atlas and Gene Expression Omnibus databases were screened for zinc metabolismrelated genes using the Molecular Signature Database . Cox and Least Absolute Shrinkage and Selection Operator regressions were performed to construct a ZMRG signature . To assess the predictive performance of the gene signature, Kaplan–Meier analysis and receiver operating characteristic curves were used. Additionally, we utilised single-sample gene set enrichment analysis, the Tumour Immune Estimation Resource, the Genomics of Drug Sensitivity in Cancer database, and the Cancer Therapeutics Response Portal to investigate the association between the tumour microenvironment and drug sensitivity. Quantitative PCR was used to assess the expression of each gene in the signature in breast cancer cell lines and patient samples.  \nResults: Five ZMRGs were identiﬁed (ATP7B, BGLAP, P2RX4, SLC39A11, and TH) and a risk proﬁle was constructed for each. Two risk groups, high-and low-risk, were identiﬁed in this way, and the high-risk score subgroups were found to have worse prognosis. This risk proﬁle was validated using the GSE42568 dataset. Tumour microenvironment and drug sensitivity analyses showed that the expression of these ﬁve ZMRGs was signiﬁcantly associated with immune response. The high-risk group showed substantial immune cell inﬁltration and enrichment of immune pathways, and patients were more sensitive to drugs commonly used in breast cancer.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusion: The ZMRG signature represents a new prognostic predictor for patients with breast cancer, and may also provide new insights into individualised treatment of breast cancer.  \nKEYWORDS  \nzinc metabolism, breast cancer, prognosis, tumour microenvironment, signature  \n1 Introduction  \nBreast cancer (BC), which has been increasing in incidence over the past few decades, is the most prevalent cancer globally and continues to be responsible f","cbCaimvIDbDXUWRh","https://ap.wps.com/l/cbCaimvIDbDXUWRh","pdf",3420334,12,"English","# Introduction\n## Breast cancer background and clinical challenge\n## Zinc metabolism biology and cancer relevance\n# Methods\n## Data sources and ZMRG screening\n## Signature construction and validation\n## Immune, drug sensitivity, and experimental validation\n# Results\n## Identification of ZMRGs and risk groups\n## Prognostic performance validation\n## Links to tumour microenvironment and drug sensitivity\n# Conclusion","[{\"question\":\"What was the study designed to achieve regarding zinc and breast cancer?\",\"answer\":\"To develop a zinc metabolism-related gene (ZMRG) signature that predicts prognosis and clarifies how zinc-related genes relate to drug therapy response and immune enrichment.\"},{\"question\":\"How many ZMRGs were identified, and what does the signature do?\",\"answer\":\"Five ZMRGs (ATP7B, BGLAP, P2RX4, SLC39A11, and TH) were identified, and the signature generated risk profiles that split patients into high- and low-risk groups.\"},{\"question\":\"What did the study find about high-risk patients and tumour microenvironment?\",\"answer\":\"High-risk groups showed worse prognosis and displayed substantial immune cell infiltration and enrichment of immune pathways, with higher sensitivity to commonly used breast cancer drugs.\"}]","A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer | PDF",1790006741]